Kalaris Therapeutics (KLRS) Equity Ratio (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Equity Ratio data on record, last reported at 0.95 in Q3 2020.
- For Q3 2020, Equity Ratio changed N/A year-over-year to 0.95; the TTM value through Sep 2020 reached 0.95, changed N/A, while the annual FY2019 figure was 0.37, N/A changed from the prior year.
- Equity Ratio reached 0.95 in Q3 2020 per KLRS's latest filing, up from 0.6 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.95 in Q3 2020 and bottomed at 0.6 in Q2 2020.